[Clinical results of administration of gestagens (Anovlar 21 and Lyndiol 2,5) in endometriosis]

E Laudańska, Laudańska E
Ginekologia polska · 1968 · vol. 39(9) , pp. 1015–20 · PMID:4881514 · W2412172964
Non-randomised trial OA: closed CC0
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View on OpenAlex View on PubMed
⚙ AI-generated summary by qwen3.7-flash, 2026-11-04 ⓘ

This clinical trial evaluated the therapeutic outcomes of administering the gestagens Anovlar 21 and Lyndiol 2.5 to patients diagnosed with endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Contraceptives, Oral Endometriosis Lynestrenol Mestranol Norethindrone Clinical Trials as Topic Clinical Trials as Topic Contraceptives, Oral Contraceptives, Oral Endometriosis Endometriosis Female Female Humans Humans Lynestrenol Lynestrenol Mestranol Mestranol Norethindrone

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-11-06T06:14:58.568748+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:57:33.264577+00:00
License: CC0 · commercial use OK